Evidence map›Paper›PMID 42544178›Full record

ReviewNigerian medical journal : journal of the Nigeria Medical Association

Use of Oral Sildenafil in the Management of Persistent Pulmonary Hypertension of the Newborn: A Case Report and Review of Literature.

Aondoaseer Michael, Ramatu Jummai Abdallah, Adaora Blessing Ogiator, Anita Obianamma Ejideh, Rose Okwunu Abah, A Michael, R J Abdallah, A B Ogiator, A O Ejideh, R O Abah

Abstract readReview
In one paragraph

Review in Nigerian medical journal : journal of the Nigeria Medical Association. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Aondoaseer MichaelGeneral Hospital, Ifako-Ijaiye, College Road, Ifako, Lagos. (BDS;FMCFD).
Ramatu Jummai AbdallahGeneral Hospital, Ifako-Ijaiye, College Road, Ifako, Lagos. (BDS;FMCFD).
Adaora Blessing OgiatorNigeria Police Force, Police Hospital Falomo, Ikoyi, Lagos.(MBCh.B; DipFHID; FMCPath).
Anita Obianamma EjidehNigeria Police Force, Police Hospital Falomo, Ikoyi, Lagos.(MBCh.B; DipFHID; FMCPath).
Rose Okwunu AbahOral and Maxillofacial, Department, Dental Centre, General Hospital, Lagos Island.(BDS; MSc Cell biology; FMCDS).
A MichaelGeneral Hospital, Ifako-Ijaiye, College Road, Ifako, Lagos. (BDS;FMCFD).
R J AbdallahGeneral Hospital, Ifako-Ijaiye, College Road, Ifako, Lagos. (BDS;FMCFD).
A B OgiatorNigeria Police Force, Police Hospital Falomo, Ikoyi, Lagos.(MBCh.B; DipFHID; FMCPath).
A O EjidehNigeria Police Force, Police Hospital Falomo, Ikoyi, Lagos.(MBCh.B; DipFHID; FMCPath).
R O AbahOral and Maxillofacial, Department, Dental Centre, General Hospital, Lagos Island.(BDS; MSc Cell biology; FMCDS).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Persistent pulmonary hypertension of the newborn (PPHN) arises from failure of the normal circulatory transition that occurs postnatally and is characterised by increased pulmonary vascular resistance, leading to significant respiratory distress and hypoxaemia. Oral sildenafil administration is a potential alternative treatment for PPHN, especially when inhaled nitric oxide is unavailable. A 72-hour-old term male neonate was referred on account of respiratory distress, and cyanosis was noticed at 30 minutes of life with RR of 76 bpm and SPO2 of 57% in room air. The baby was pale, cyanosed, icteric, and febrile (39.5°C). An initial assessment of Severe NNJ 2

Indexed as

Case ReportCyanosisNeonateNigeriaPersistent Pulmonary Hypertension of the NewbornResource-Limited SettingSildenafil

Identifiers

PMID42544178
PMCPMC13429084

What Socratic holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.